Global Uterine Tissue Removal Systems Market: Overview

Uterine tissue removal systems are used to remove uterine fibroids among women, as a part of gynecology procedures such as myomectomy, endometrial biopsy, and polypectomy. The Symphion Tissue Removal System manufactured by Boston Scientific Corporation includes a controller, hysteroscope, resecting device, and fluid management accessories which together help in management of uterine fibroids.

Global Uterine Tissue Removal Systems Market: Key Trends

The global uterine tissue removal systems market is driven by rise in prevalence of gynecology disorders such as uterine fibroids, surge in the number of surgical procedures in gynecology, and increase in importance of women’s health in developed and developing regions across the globe. Additionally, high demand for technologically advanced gynecology solutions in emerging markets in Asia Pacific offers significant opportunities in the global market.

Global Uterine Tissue Removal Systems Market: Segmentation

The global uterine tissue removal systems market can be segmented based on application, end-user, and region. In terms of application, the market can be classified into myomectomy, endometrial biopsy, polypectomy, hysteroscopic adhesiolysis, and others. The myomectomy segment is projected to grow at a rapid pace during the forecast period due to increase in the number of myomectomies at surgical centers and hospitals. Based on end-user, the global uterine tissue removal systems market can be categorized into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centers segment is expected to expand at a high CAGR in the next few years, owing to increase in the number of women preferring ambulatory centers for gynecological procedures and rise in the availability of technologically advanced surgical systems in these centers.

Global Uterine Tissue Removal Systems Market: Regional Analysis

The global uterine tissue removal systems market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to account for the largest market share during the forecast period. The U.S. was the major market in the region, followed by Canada. The uterine tissue removal systems market in the U.S. is driven by increase in demand for in-office gynecology procedures and growing concerns on women health including addiction to smoking, lack of exercise and dietary habits leading to hormonal changes and pain during periods. Moreover, geographical expansion and launch of new products by key players are projected to boost the growth of the market in the country during the forecast period. For instance, in November 2017, Hologic, Inc. announced the launch of MyoSure MANUAL device for removal of intrauterine tissue. It provides easy resection and removal of uterine tissue in office settings. The device can be used with MyoSure hysteroscope. Through this launch, the company expanded its product portfolio and innovative solutions in gynecology.

The uterine tissue removal market in Europe is anticipated to grow at a rapid pace during the forecast period due to high R&D investments by major players in the field of gynecological and availability of funds offered by governments for R&D. The market in Asia Pacific is expected to expand at a high CAGR from 2018 to 2026 due to rise in the number of gynecology procedures in hospitals, increase in the number of women with reproductive and other health issues, and surge in government campaigns for women’s health and maternity care in rural areas. Moreover, increase in availability of well-equipped gynecology centers with qualified & experienced surgeons and physicians contributes to the growth of the market in Asia Pacific. In India, major health concerns leading to development of uterine fibroids among women are severe anemia and menorrhagia. A research conducted by Shri Sathya Sai Medical College and Research Institute revealed that out of 362 women included in the study uterine, 37.65% of the women had uterine fibroids.

Global Uterine Tissue Removal Systems Market: Competitive Landscape

Key players operating in the global uterine tissue removal systems market are Boston Scientific Corporation, Hologic, Inc., Medtronic, and Smith & Nephew.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Uterine Tissue Removal Systems Market

Pre Book